PARP Inhibitors in Advanced Prostate Cancer Care Podcast
CME Available: https://auau.auanet.org/node/37321
Host: Jay D. Raman, MD, FACS
Guests: Maha Hussain, MD and Ganesh Raj, MD, PhD
LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:
1. Identify approved PARP Inhibitors for prostate cancer and patients who may benefit ... Show More
Nov 4
Update Series (2026): Antibiotic Stewardship in Office Urology—A Case-Based Approach
Update Series (2026): Antibiotic Stewardship in Office Urology—A Case-Based Approach Host: Mark L. Gonzalgo, MD, PhD, MBA Guest: E. Ann Gormley, MD, MSc Now in its 45th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fe ... Show More
20m 21s
Mar 2022
Robert Dreicer, MD, MS, MACP, FASCO - Decisions and Dilemmas in Prostate Cancer Management: Building on Progress to Advance Personalized Care Through Candid Conversations and Expert Clinical Consults
Go online to PeerView.com/GZF860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Clinicians who treat patients with prostate cancer have new opportunities to improve outcomes across a variety of settings, but the rapid expansion ... Show More
1h 21m
Oct 2023
Early-Stage Prostate Cancer: Know Your Treatment Options
Learn what you need to know about early-stage prostate cancer, from risk factors to treatment options and how to tackle their side effects. In this episode, Dr. Diane Reidy-Lagunes is joined by medical oncologist Dr. Dana Rathkopf, radiation oncologist Dr. Sean McBride, and urolo ... Show More
25m 8s
Jan 2024
Episode 087: Prostate Cancer Series: Pt. 4- Radiation Oncology in Prostate Cancer
<p class="" style="white-space:pre-wrap;">Last, but not least, in our multidisciplinary discussions regarding the management of prostate cancer, we are thrilled to present a special episode featuring soon-to-be attending Radiation Oncologist Dr. Jacob Hall. Dr. Hall is a senior R ... Show More
41 m
May 2022
Bradley J. Monk, MD, FACS, FACOG - When Are PARP Inhibitors the Best Choice for Patients With Ovarian Cancer? Personalizing Therapeutic Selection Across the Disease Continuum
Go online to PeerView.com/YWA860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. Are you optimizing the care of your patients with ovarian cancer with poly (ADP-ribose) polymerase (PARP) inhibitors and novel therapies such as tu ... Show More
56m 25s